Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M709230200 on March 3, 2008

J. Biol. Chem., Vol. 283, Issue 19, 13450-13458, May 9, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/19/13450    most recent
M709230200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callejas-Valera, J. L.
Right arrow Articles by Sánchez-Prieto, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callejas-Valera, J. L.
Right arrow Articles by Sánchez-Prieto, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

E1a Gene Expression Blocks the ERK1/2 Signaling Pathway by Promoting Nuclear Localization and MKP Up-regulation

IMPLICATION IN v-H-Ras-INDUCED SENESCENCE*Formula

Juan L. Callejas-Valera{ddagger}1, Juan Guinea-Viniegra{ddagger}12, Carmen Ramírez-Castillejo{ddagger}1, Juan A. Recio§, Eva Galan-Moya{ddagger}, Natalia Martinez§, Jose M. Rojas§, Santiago Ramón y Cajal||, and Ricardo Sánchez-Prieto{ddagger}3

From the {ddagger}Centro Regional Investigaciones Biomédicas/Facultad de Medicina, Universidad de Castilla la Mancha, Albacete 02006, the §Programa de Oncología Médica, Institut de Recerca Vall d'Hebron Hospital, Universitario Vall d'Hebron, Barcelona 08035, the Unidad de Biología Celular, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid 28220, and the ||Servicio de Anatomía Patológica, Hospital Universitario Vall d'Hebron, Barcelona 08035, Spain

In response to oncogenic signals, cells have developed safe mechanisms to avoid transformation through activation of a senescence program. Upon v-H-Ras overexpression, normal cells undergo senescence through several cellular processes, including activation of the ERK1/2 pathway. Interestingly, the E1a gene from adenovirus 5 has been shown to rescue cells from senescence by a yet unknown mechanism. We investigated whether E1a was able to interfere with the ERK1/2 signaling pathway to rescue cells from v-H-Ras-mediated senescence. Our results show that, E1a overexpression blocks v-H-Ras-mediated ERK1/2 activation by two different and concomitant mechanisms. E1a through its ability to interfere with PKB/Akt activation induces the down-regulation of the PEA15 protein, an ERK1/2 nuclear export factor, leading to nuclear accumulation of ERK1/2. In addition to this, we show that E1a increases the expression of the inducible ERK1/2 nuclear phosphatases (MAPK phosphatases) MKP1/DUSP1 and DUSP5, which leads to ERK1/2 dephosphorylation. We confirmed our observations in the human normal diploid fibroblasts IMR90, in which we could also show that an E1a mutant, unable to bind retinoblastoma protein (pRb), cannot rescue cells from v-H-Ras-induced senescence. In conclusion, E1a is able to rescue from Ras-induced senescence by affecting ERK1/2 localization and phosphorylation.


Received for publication, November 9, 2007 , and in revised form, February 15, 2008.

* This work was supported by grants from the Fundación Leticia Castillejo Castillo, Conserjería de Educación y Ciencia JCCM Grant PAI07-0012-0393 and Ministerio de Educación y Ciencia Grant SAF 2006/01479 (to R. S. P.), and Ministerio de Educación y Ciencia Grant SAF2006-04247 and ISCIII-RETIC RD06/0020 from the Ministerio de Sanidad y Consumo (to J. M. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S5.

1 These authors have contributed equally to this work.

2 Present address: Institute of Molecular Pathology, Vienna, Austria.

3 To whom correspondence should be addressed. Tel.: 34-967599200 (ext. 2981); Fax: 34-967599327; E-mail: ricardo.sanchez{at}uclm.es.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
P. Bhat-Nakshatri, G. Wang, H. Appaiah, N. Luktuke, J. S. Carroll, T. R. Geistlinger, M. Brown, S. Badve, Y. Liu, and H. Nakshatri
AKT Alters Genome-Wide Estrogen Receptor {alpha} Binding and Impacts Estrogen Signaling in Breast Cancer
Mol. Cell. Biol., December 15, 2008; 28(24): 7487 - 7503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement